Which of the “Six Foods” Would You Eliminate First?

The target action date for the FDA decision is April 18, 2025, according to Sanofi and Regeneron.

Recurrent C difficile requires pulse vancomycin therapy; fecal microbiota transplant shows promise.

ACAAI 2024. Two studies here showed that anaphylaxis protocols for EMS are outdated in many states and that many patients don't know how to use epinephrine.

The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.

Your daily dose of the clinical news you may have missed.

neffy (epinephrine nasal spray) is the first alternative to epinephrine administered by autoinjector or syringe and is comparable in efficacy to the gold standard.